Immunological evidence for methylglyoxal-derived modifications in vivo

被引：0
|
作者：
Shamsi, FA
Nagaraj, RH
机构：
来源：
DIABETES | 1998年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
444
引用
收藏
页码：A113 / A113
页数：1
相关论文
共 50 条
  • [41] Inhibitory effect of herbal medicines and their trapping abilities against methylglyoxal-derived advanced glycation end-products
    Sompong, Weerachat
    Adisakwattana, Sirichai
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [42] The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
    Heier, Martin
    Margeirsdottir, Hanna Dis
    Torjesen, Peter Abusdal
    Seljeflot, Ingebjorg
    Stensaeth, Knut Haakon
    Gaarder, Mario
    Brunborg, Cathrine
    Hanssen, Kristian Folkvord
    Dahl-Jorgensen, Knut
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (02): : 139 - 145
  • [43] Development of a dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA) for methylglyoxal-derived advanced glycation end-products.
    Yeo, KT
    Bateman, SW
    Brownlee, M
    Beisswenger, PJ
    CLINICAL CHEMISTRY, 2001, 47 (06) : A19 - A20
  • [44] Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women
    Kilhovd, Bente K.
    Juutilainen, Auni
    Lehto, Seppo
    Roennmaa, Tapani
    Torjesen, Peter A.
    Hanssen, Kristian F.
    Laakso, Markku
    ATHEROSCLEROSIS, 2009, 205 (02) : 590 - 594
  • [45] Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction
    Blackburn, Nick J. R.
    Vulesevic, Branka
    McNeill, Brian
    Cimenci, Cagla Eren
    Ahmadi, Ali
    Gonzalez-Gomez, Mayte
    Ostojic, Aleksandra
    Zhong, Zhiyuan
    Brownlee, Michael
    Beisswenger, Paul J.
    Milne, Ross W.
    Suuronen, Erik J.
    BASIC RESEARCH IN CARDIOLOGY, 2017, 112 (05)
  • [46] Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction
    Nick J. R. Blackburn
    Branka Vulesevic
    Brian McNeill
    Cagla Eren Cimenci
    Ali Ahmadi
    Mayte Gonzalez-Gomez
    Aleksandra Ostojic
    Zhiyuan Zhong
    Michael Brownlee
    Paul J. Beisswenger
    Ross W. Milne
    Erik J. Suuronen
    Basic Research in Cardiology, 2017, 112
  • [47] One-Step Synthesis of 2,5-Diaminoimidazoles and Total Synthesis of Methylglyoxal-Derived Imidazolium Crosslink (MODIC)
    Sabbasani, Venkata R.
    Wang, Kung-Pern
    Streeter, Matthew D.
    Spiegel, David A.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (52) : 18913 - 18917
  • [48] Inhibitory Effect of Arachis hypogaea (Peanut) and Its Phenolics against Methylglyoxal-Derived Advanced Glycation End Product Toxicity
    Park, Sin Hee
    Do, Moon Ho
    Lee, Jae Hyuk
    Jeong, Minsun
    Lim, Oh Kyung
    Kim, Sun Yeou
    NUTRIENTS, 2017, 9 (11):
  • [49] Methylglyoxal-derived hemoglobin advanced glycation end products induce apoptosis and oxidative stress in human umbilical vein endothelial cells
    Lee, Jae Hyuk
    Samsuzzaman, Md.
    Park, Myoung Gyu
    Park, Sung Jean
    Kim, Sun Yeou
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 187 : 409 - 421
  • [50] Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone, is elevated in young, complication-free patients with Type 1 diabetes
    Han, Y.
    Randell, E.
    Vasdev, S.
    Gill, V.
    Curran, M.
    Newhook, L.
    Grant, M.
    Hagerty, D.
    Schneider, C.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A174 - A174
12345